Chester County News and Community Website
MyChesCo’s Regional News is your go-to source for news and information about southeastern Pennsylvania. Our team of reporters and editors are all based in the region, so we have an intimate understanding of the issues that matter to our readers. Our coverage includes everything from local politics and business to education and the arts, and we strive to ensure that our readers always get the most accurate and up-to-date information.
We cover all the major cities and towns in southeastern Pennsylvania, including Philadelphia, Bucks County, Berks County, Cecil County, Maryland, Delaware County, Montgomery County, Wilmington, Delaware, and New Castle County, Delaware. Our team works hard to track down the facts and deliver comprehensive coverage of the region.
MyChesCo’s Regional News is your one-stop shop for reliable news and information about southeastern Pennsylvania. Whether you’re looking for breaking news or in-depth analysis, you’ll find everything you need all in one place. So don’t wait – start exploring our Regional News section today and stay informed about what’s happening in southeastern Pennsylvania.
PHILADELPHIA, PA — In a city celebrated for its rich tapestry of cultures and languages, Philadelphia International Airport (PHL) is taking significant strides to ensure that its global visitors feel …
Philadelphia International Airport Enhances Guest Experience with Multilingual Support Services Read More
PHILADELPHIA, PA — Axalta Coating Systems Ltd. (NYSE: AXTA), a leading global coatings provider, disclosed today that Robert M. McLaughlin, a distinguished member of its Board of Directors since 2014, …
Axalta Coating Systems Announces Board Retirement and Succession Plan Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX), a biopharmaceutical company specializing in the development of treatments for solid tumors and gynecological cancers, has unveiled its financial outcomes for the …
Context Therapeutics Adjusts Strategy and Reports Financial Update Amidst R&D Pivot Read More
PHILADELPHIA, PA — The biotech company Cabaletta Bio, Inc. (Nasdaq: CABA), known for its pioneering work in autoimmune disease therapeutics, recently announced its financial results and business updates for the …
Cabaletta Bio Forges Ahead: A Strong Year Lays Groundwork for Groundbreaking Autoimmune Disease Therapies Read More
PHILADELPHIA, PA — In a significant move towards expanding its renewable energy footprint, Doral Renewables LLC recently announced the closure of a substantial construction debt financing deal, amounting to $114 …
Doral Renewables Secures $114 Million Financing for Ohio Solar Project with HSBC Partnership Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has unfurled its financial banners for the fourth quarter and full year closing December 31, 2023. Alongside these fiscal results, the company …
Targeting the Heart of the Matter – Mineralys Therapeutics In Pursuit of Transformative Treatments for Hypertension and Adjacent Conditions Read More
WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC), a leading innovator in mobile technologies and wireless systems, has announced a regular quarterly cash dividend of $0.40 per share on its common …
InterDigital Announces Quarterly Cash Dividend of $0.40 Per Share Read More
PHILADELPHIA, PA — Five Below Inc., the Philadelphia-based retailer much-loved for its wide range of products retailing for $5 or less, recently closed its fiscal year 2023 on a high …
Five Below Inc. Announces Record Sales and Profitability: A Strategic Success Story Amid Global Market Fluctuations Read More
PHILADELPHIA, PA — In a significant advancement for cancer research and medical education, the Philadelphia College of Osteopathic Medicine (PCOM) and The Wistar Institute have announced the creation of a new …
Philadelphia College of Osteopathic Medicine and The Wistar Institute Launch Joint Cancer Biology Ph.D. Program Read More PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced that the U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to its investigational therapy, CABA-201. This designation …
Cabaletta Bio Receives FDA Orphan Drug Designation for Innovative Autoimmune Disease Therapy Read More